AIMS: To study the role of the mannan binding lectin (MBL) pathway of complement activation in the host defence to microbial infection in vivo, and the role of MBL in infectious mortality in non-selected patients. METHODS: A prospective observational study on 177 hospitalised medical patients with new onset fever. The presence, origin, and microbial cause of infection, the circulating MBL and complement activation product 3a (C3a), and the 28 day hospital course were determined. RESULTS: The patients had median MBL values similar to healthy blood donors: 18% of the patients and 14% of the blood donors had MBL deficiency, with values below 0.1 microg/ml. Median C3a was higher in patients with microbiologically confirmed infection than in those without, whereas there was no difference in MBL values or frequency of deficiency among patient groups with or without positive local cultures or bacteraemia. The mortality rate was 8% and the outcome groups did not differ in MBL. In febrile adults hospitalised in internal medicine wards, microbial infection induces complement activation, independently of MBL. CONCLUSIONS: The results argue against a predominant role for the MBL pathway of complement activation and a deficiency of MBL predisposing to serious and invasive microbial infection in non-selected adults.
AIMS: To study the role of the mannan binding lectin (MBL) pathway of complement activation in the host defence to microbial infection in vivo, and the role of MBL in infectious mortality in non-selected patients. METHODS: A prospective observational study on 177 hospitalised medical patients with new onset fever. The presence, origin, and microbial cause of infection, the circulating MBL and complement activation product 3a (C3a), and the 28 day hospital course were determined. RESULTS: The patients had median MBL values similar to healthy blood donors: 18% of the patients and 14% of the blood donors had MBL deficiency, with values below 0.1 microg/ml. Median C3a was higher in patients with microbiologically confirmed infection than in those without, whereas there was no difference in MBL values or frequency of deficiency among patient groups with or without positive local cultures or bacteraemia. The mortality rate was 8% and the outcome groups did not differ in MBL. In febrile adults hospitalised in internal medicine wards, microbial infection induces complement activation, independently of MBL. CONCLUSIONS: The results argue against a predominant role for the MBL pathway of complement activation and a deficiency of MBL predisposing to serious and invasive microbial infection in non-selected adults.
Authors: Charles G Mullighan; Sue Heatley; Kathleen Doherty; Ferenc Szabo; Andrew Grigg; Timothy P Hughes; Anthony P Schwarer; Jeff Szer; Brian D Tait; L Bik To; Peter G Bardy Journal: Blood Date: 2002-05-15 Impact factor: 22.113
Authors: Gitte Kronborg; Nina Weis; Hans O Madsen; Svend S Pedersen; Christian Wejse; Henrik Nielsen; Peter Skinhøj; Peter Garred Journal: J Infect Dis Date: 2002-04-23 Impact factor: 5.226
Authors: Suchismita Roy; Kyle Knox; Shelley Segal; David Griffiths; Catrin E Moore; Kenneth I Welsh; Alex Smarason; Nicholas P Day; William L McPheat; Derrick W Crook; Adrian V S Hill Journal: Lancet Date: 2002-05-04 Impact factor: 79.321
Authors: F N J Frakking; N Brouwer; K M Dolman; J B M van Woensel; H N Caron; T W Kuijpers; M D van de Wetering Journal: Clin Exp Immunol Date: 2011-04-13 Impact factor: 4.330
Authors: F N J Frakking; N Brouwer; N K A van Eijkelenburg; M P Merkus; T W Kuijpers; M Offringa; K M Dolman Journal: Clin Exp Immunol Date: 2007-08-17 Impact factor: 4.330
Authors: J W Olivier van Till; Piet W Modderman; Martin de Boer; Margreet H L Hart; Marcel G H M Beld; Marja A Boermeester Journal: Clin Vaccine Immunol Date: 2007-10-31
Authors: Thorsten Thye; Stefan Niemann; Kerstin Walter; Susanne Homolka; Christopher D Intemann; Margaret Amanua Chinbuah; Anthony Enimil; John Gyapong; Ivy Osei; Ellis Owusu-Dabo; Sabine Rüsch-Gerdes; Rolf D Horstmann; Stefan Ehlers; Christian G Meyer Journal: PLoS One Date: 2011-06-10 Impact factor: 3.240
Authors: Michael Siassi; Jutta Riese; Rudi Steffensen; Michael Meisner; Steffen Thiel; Werner Hohenberger; Joachim Schmidt Journal: Crit Care Date: 2005-07-19 Impact factor: 9.097
Authors: Koert M Dolman; Nannette Brouwer; Florine N J Frakking; Berit Flatø; Paul P Tak; Taco W Kuijpers; Oystein Førre; Anna Smerdel-Ramoya Journal: Arthritis Res Ther Date: 2008-03-11 Impact factor: 5.156